Vibrio Cholerae as a bioterror agent: New means of treating a potential pandemic
Vibrio Cholerae as a bioterror agent: New means of treating a potential pandemic
批准号:
7253855
负责人:
Anjaparavanda P Naren
金额:
$7.3万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-01 至 2009-02-28
关键词:
AgonistBioterrorismBloodBody Weight decreasedCabbage - dietaryCategoriesCholeraCholera ToxinCystic Fibrosis Transmembrane Conductance RegulatorDataDiarrheaDiseaseEgg WhiteExhibitsFluids and SecretionsFoodFood SupplyGastrointestinal tract structureGlycine maxGoalsGram-Negative BacteriaInflammatory Bowel DiseasesIntestinesLecithinLysophosphatidic Acid ReceptorsLysophospholipidsMethodsMusNational Institute of Allergy and Infectious DiseaseNew AgentsOral Rehydration TherapyPharmaceutical PreparationsPropertyReagentResearchResistanceSoybeansTestingTherapeuticVibrio choleraeWaterWater Supplybaseconceptinhibitor/antagonistlipid mediatorlipid phosphate phosphataselysophosphatidic acidpandemic diseasepathogen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cholera is a serious diarrheal disease and is caused by Vibrio cholerae a gram negative bacterium and has the potential to be used as a bioterror weapon by contaminating water and food supplies. The National Institute of Allergy and Infectious Diseases (NIAID) has categorized V. cholerae as category "B" pathogen that posses a potential bioterrorism threat. Lysophosphatidic acid (LPA) is a lipid mediator present in blood and foods. LPA has been shown to be an LPA-receptor agonist and is beneficial in reducing weight loss in inflammatory bowel disease and diarrhea. We will provide preliminary data to show that intestinal fluid secretion induced by cholerae toxin (CTX) in mice is significantly reduced by LPA administration. Based on this observation, the proposed research will test the hypothesis that foods rich in LPA and stabilized synthetic LPA-receptor agonists can inhibit CTX-induced secretory diarrhea in mice. Therefore the use of lipid mediators such as LPA and its anologs in addition to oral rehydration therapy would have value in treating V. cholerae pandemic.
The specific aims of this proposal are:
Aim 1: To test if foods rich in LPA will inhibit CTX-induced diarrhea in mice.
Aim 2: To test if metabolically stabilized synthetic LPA-receptor agonists exhibit potent anti- diarrheal properties (compared to LPA).
These studies will demonstrate that cholera toxin-induced diarrhea can be controlled by consuming foods rich in LPA. It will also help us test and develop drugs that may have therapeutic potential. It will help move us toward the long-term goal of understanding the lipid mediators which (e.g., LPA) can regulate the CFTR Cl- channel function. The results of these studies will provide us with possible alternative methods of treating diseases of the gastrointestinal tract such as secretory diarrhea, that can be caused due to an act of bioterror such as contaminating food and water supplies with V. cholerae or due to natural causes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
-
批准号:10406127
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2020
-
负责人:Anjaparavanda P Naren
-
依托单位:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
-
批准号:10454293
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2020
-
负责人:Anjaparavanda P Naren
-
依托单位:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
-
批准号:10656430
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Model System Core
-
批准号:10249242
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Administrative Core
-
批准号:10477250
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Administrative Core
-
批准号:10249240
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Administrative Core
-
批准号:10017685
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Cystic Fibrosis Therapy and Research Center
-
批准号:10672704
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Model System Core
-
批准号:10477252
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Personalized Model System Core
-
批准号:10017687
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2018
-
负责人:Anjaparavanda P Naren
-
依托单位:
Human Enteroids, Colonoids, and iPSC derived HIO's to study CFTR-relatedDisorders
-
批准号:9551790
-
项目类别:
-
资助金额:$10.24万
-
财政年份:2017
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8698411
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8755868
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:9284460
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8500254
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8300093
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
LPA2 receptor-containing complexes in regulating secretory diarrhea
-
批准号:8192003
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2011
-
负责人:Anjaparavanda P Naren
-
依托单位:
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea
-
批准号:7753861
-
项目类别:
-
资助金额:$36.24万
-
财政年份:2009
-
负责人:Anjaparavanda P Naren
-
依托单位:
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea
-
批准号:8207256
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2009
-
负责人:Anjaparavanda P Naren
-
依托单位:
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea
-
批准号:8622190
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2009
-
负责人:Anjaparavanda P Naren
-
依托单位:
海外基金